Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Am Heart J. 2012 Oct 26;164(6):918–924. doi: 10.1016/j.ahj.2012.09.004

Table VI.

Outcomes, Stratified by the Development of POAF among Patients without Pre-existing Atrial Fibrillation*

Outcomes POAF (N=3602) No POAF (N=339003) Unadjusted OR [95% CI] P value Adjusted OR [95% CI] P value
Mortality 570 (15.8%) 6646 (2.0%) 9.40 [8.57–10.31] <0.001 1.68 [1.52–1.86] <0.001
Readmission 30 days 529 (14.7%) 32338 (9.5%) 1.63 [1.49–1.79] <0.001 1.02 [0.92–1.14] 0.673
Unadjusted Difference in Means [95% CI] Adjusted Difference in Means [95% CI]
Length of Stay, median, [IQR] 13 [8–22] 4 [3–7] +275% [268%–182%] <0.001 + 37.3% [33.9%–40.9%] <0.001
Hospitalization Cost, median, [IQR] 25205 [18041–36280] +14525 [10202–20987] +10617 [10224–11011] <0.001 + 5914 [5416–6412] <0.001

Abbreviations: POAF, Post-operative atrial fibrillation

*

Patients with pre-existing atrial fibrillation, as determined by present-on-admission coding, were excluded from this analysis

Length of stay log transformed in adjusted and unadjusted models, length of stay is in days

top 5th percentile of cost removed to reduce skewness, cost is in dollars